Calumet (CLMT) Stock Price, News & Analysis

Company Overview

Calumet, Inc. engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulations businesses, covering multiple specialty product lines, anchored by a unique integrated complex in Northwest Louisiana. The Performance Brands segment includes a fast-growing portfolio of high-quality, high performing brands. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Corporate segment focuses on the general and administrative expenses not allocated to the Montana/Renewables, Specialty Products and Solutions, or Performance Brands segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.

Key Stats

• Today's Range: $16.42 to $17.00
• 50-Day Range: $13.17 to $17.14
• 52-Week Range: $7.68 to $25.29
• Volume: 602,173 shs
• Average Volume: 745,153 shs
• Market Capitalization: $1.45 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.50
• Consensus Rating: Moderate Buy

Calumet Stock Analysis - MarketRank™

Calumet scored higher than 20% of companies evaluated by MarketBeat, and ranked 236th out of 266 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Calumet has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Calumet has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Calumet are expected to grow in the coming year, from ($3.02) to $0.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Calumet is -4.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Calumet is -4.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.66% of the float of Calumet has been sold short.

Short Interest Ratio / Days to Cover

Calumet has a short interest ratio ("days to cover") of 7.7.

Change versus previous month

Short interest in Calumet has recently increased by 10.93%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Calumet does not currently pay a dividend.

Dividend Growth

Calumet does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

13.66% of the float of Calumet has been sold short.

Short Interest Ratio / Days to Cover

Calumet has a short interest ratio ("days to cover") of 7.7.

Change versus previous month

Short interest in Calumet has recently increased by 10.93%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 1.51

News Sentiment

Calumet has a news sentiment score of 1.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Energy companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Calumet this week, compared to 4 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Calumet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,113,303.00 in company stock.

Percentage Held by Insiders

Only 4.07% of the stock of Calumet is held by insiders.

Percentage Held by Institutions

Only 34.41% of the stock of Calumet is held by institutions.

CLMT Stock Analysis - Frequently Asked Questions

How have CLMT shares performed this year?

Calumet's stock was trading at $22.02 at the beginning of 2025. Since then, CLMT stock has decreased by 23.7% and is now trading at $16.81.

How were Calumet's earnings last quarter?

Calumet, Inc. (NASDAQ:CLMT) posted its quarterly earnings results on Friday, May, 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by $0.62. The business's quarterly revenue was down 1.2% on a year-over-year basis.
Read the conference call transcript.

Does Calumet have any subsidiaries?

Calumet subsidiaries include Biosynthetic Technologies, Specialty Oil Field Solutions, Anchor Drilling Fluids USA, United Petroleum Company, Bel-Ray, Montana Renewables, Royal Purple, and more.

Who are Calumet's major shareholders?

Top institutional shareholders of Calumet include Wasserstein Debt Opportunities Management L.P. (6.75%), Adams Asset Advisors LLC (6.27%), Valeo Financial Advisors LLC (0.04%) and O Keefe Stevens Advisory Inc. (0.03%). Insiders that own company stock include Jennifer Straumins, James S Carter, Stephen P Mawer, Scott Obermeier, Daniel J Sajkowski, Louis Todd Borgmann, Gregory J Morical, Ryan Willman and David Lunin.
View institutional ownership trends.

How do I buy shares of Calumet?

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Calumet own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Calumet investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investments (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM) and Summit Midstream Partners (SMLP).

Company Calendar

• Last Earnings: 5/09/2025
• Today: 7/28/2025
• Next Earnings (Estimated): 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Energy
• Industry: OIL - US INTEGRTD
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NASDAQ:CLMT
• CIK: 1340122
• Web: www.calumetspecialty.com
• Phone: (317) 328-5660
• Fax: 317-328-2359
• Employees: 1,620
• Year Founded: 1916

Price Target and Rating

• Average Price Target for Calumet: $18.50
• High Price Target: $33.00
• Low Price Target: $12.00
• Potential Upside/Downside: +10.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$222 million
• Net Margins: -8.20%
• Pretax Margin: -8.17%
• Return on Equity: N/A
• Return on Assets: -8.77%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.06
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: $4.19 billion
• Price / Sales: 0.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($8.28) per share
• Price / Book: -2.03

Miscellaneous

• Outstanding Shares: 86,210,000
• Free Float: 82,698,000
• Market Cap: $1.45 billion
• Optionable: Optionable
• Beta: 0.93